SecSonar.com

Petros Pharmaceuticals, Inc. (PTPI)

Petros Pharmaceuticals, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Petros Pharmaceuticals, Inc. (PTPI) is a Drug Manufacturers - Specialty & Generic company based in US with a market capitalization of $190.1K. Free cash flow was negative at -$6.7M. This page tracks PTPI's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 18 employees · IPO Dec 2, 2020

Valuation

Valuation & price

$0.01 · as of May 17, 2026 · -80.3% vs 52w high

0.9

P/E ratio

Latest-FY diluted EPS

0.00

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$0.03$0.02$0.01Jul 25Dec 25Jul 26Jul 7, 25$0.03Jul 9, 25$0.03Jul 11, 25$0.03Jul 15, 25$0.03Jul 17, 25$0.03Jul 21, 25$0.03Jul 23, 25$0.03Jul 25, 25$0.03Jul 29, 25$0.03Jul 31, 25$0.03Aug 4, 25$0.03Aug 6, 25$0.03Aug 11, 25$0.03Aug 13, 25$0.03Aug 15, 25$0.03Aug 19, 25$0.03Aug 21, 25$0.03Aug 25, 25$0.03Aug 27, 25$0.03Aug 29, 25$0.03Sep 3, 25$0.03Sep 5, 25$0.03Sep 9, 25$0.03Sep 11, 25$0.03Sep 16, 25$0.03Sep 18, 25$0.03Sep 22, 25$0.03Sep 24, 25$0.03Sep 26, 25$0.03Sep 30, 25$0.02Oct 2, 25$0.02Oct 6, 25$0.02Oct 8, 25$0.02Oct 10, 25$0.02Oct 14, 25$0.02Oct 16, 25$0.02Oct 21, 25$0.02Oct 23, 25$0.02Oct 27, 25$0.02Oct 29, 25$0.02Oct 31, 25$0.02Nov 4, 25$0.02Nov 6, 25$0.02Nov 10, 25$0.02Nov 12, 25$0.02Nov 14, 25$0.02Nov 18, 25$0.01Nov 20, 25$0.01Nov 25, 25$0.01Nov 28, 25$0.01Dec 2, 25$0.01Dec 4, 25$0.01Dec 8, 25$0.01Dec 10, 25$0.01Dec 12, 25$0.01Dec 16, 25$0.01Dec 18, 25$0.01Dec 22, 25$0.01Dec 24, 25$0.01Dec 29, 25$0.01Jan 2, 26$0.01Jan 6, 26$0.01Jan 8, 26$0.01Jan 12, 26$0.01Jan 14, 26$0.01Jan 16, 26$0.01Jan 21, 26$0.01Jan 23, 26$0.01Jan 27, 26$0.01Jan 29, 26$0.01Feb 2, 26$0.01Feb 4, 26$0.01Feb 9, 26$0.01Feb 11, 26$0.01Feb 13, 26$0.01Feb 18, 26$0.01Feb 20, 26$0.01Feb 24, 26$0.01Feb 26, 26$0.01Mar 2, 26$0.01Mar 4, 26$0.01Mar 6, 26$0.01Mar 10, 26$0.01Mar 12, 26$0.01Mar 17, 26$0.01Mar 19, 26$0.01Mar 23, 26$0.01Mar 25, 26$0.01Mar 27, 26$0.01Mar 31, 26$0.01Apr 2, 26$0.01Apr 7, 26$0.01Apr 9, 26$0.01Apr 13, 26$0.01Apr 15, 26$0.01Apr 17, 26$0.01Apr 22, 26$0.01Apr 24, 26$0.01Apr 28, 26$0.01Apr 30, 26$0.01May 4, 26$0.01May 6, 26$0.01May 8, 26$0.01May 12, 26$0.01May 14, 26$0.01May 18, 26$0.01May 20, 26$0.01May 22, 26$0.01May 28, 26$0.01Jun 1, 26$0.01Jun 3, 26$0.01Jun 5, 26$0.01Jun 9, 26$0.01Jun 11, 26$0.01Jun 15, 26$0.01Jun 17, 26$0.01Jun 22, 26$0.01Jun 24, 26$0.01Jun 26, 26$0.01Jul 2, 26$0.01
$0.0152-week range$0.03
Loading valuation history…

Fundamentals

Key fundamentals

$190.1K

Market cap

—

Revenue growth (YoY)

76.3%

Gross margin

-$6.7M

Free cash flow (USD)

-$5.1B

Net debt

Net cash position

3396.8%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2025

FY 2018$14.1MFY 2019$15.6MFY 2020$9.6MFY 2021$7.8MFY 2022$6.0MFY 2023$5.8MFY 2024$5.1MFY 2025$0.00
$14.1M$0

Free cash flow by year

2018 → 2025

FY 2018$6.1MFY 2019$2.5MFY 2020$-15.3MFY 2021$-11.9MFY 2022$-12.8MFY 2023$-7.6MFY 2024$-2.6MFY 2025$-6.7M
$6.1M-$6.7M

Gross margin by year

2021 → 2024

FY 202179.5%FY 202261.8%FY 202372.0%FY 202476.3%
79.5%76.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventEmployee Separation AgreementJun 18, 2026Filing
  • 8-K eventRestricted Stock Awards GrantedJun 5, 2026Filing
  • Quarterly report10-Q FiledMay 13, 2026Filing
  • Annual report10-K FiledApr 15, 2026Filing

Questions

Frequently asked questions

What is Petros Pharmaceuticals, Inc.'s market cap?

Petros Pharmaceuticals, Inc. (PTPI) has a market capitalization of $190.1K.

What is PTPI's P/E ratio?

PTPI trades at a price-to-earnings ratio of 0.9, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is PTPI's price-to-book (P/B) ratio?

PTPI trades at 0.00 times book value per share.

Are insiders buying PTPI stock?

SEC Form 4 filings show no open-market insider buys at Petros Pharmaceuticals, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

PRFX

PRF Technologies Ltd.

$368K

PRPH

ProPhase Labs, Inc.

$457.1K

AKAN

Akanda Corp.

$706.9K

IMCC

IM Cannabis Corp.

$1M

SXTC

China SXT Pharmaceuticals, Inc.

$1.3M

SBFM

Sunshine Biopharma, Inc.

$1.4M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.